Research Poster Abstracts

The National Hemophilia Foundation (NHF) is pleased to announce a Call for Research Poster Abstracts for our 74th Bleeding Disorders Conference in Houston, TX, from August 25-27, 2022.

NHF is seeking to showcase important research currently being conducted by physicians, researchers, nurses, physical therapists, social workers, and other healthcare professionals in the field of bleeding and clotting disorders. We encourage all members of the community to submit poster abstracts in the following categories:

  • Biomedical/Coagulation Research
  • Clinical Research/Clinical Trials
  • Collaboration/Team Models
  • Inhibitors
  • Law/Ethics/Health Policy
  • New Products
  • Orthopedic and Physical Therapy
  • Peer Support/Outreach/Integration Models
  • Psychosocial Issues
  • Quality of Life/Outcomes Research
  • Women’s Research

The deadline for submission has now passed. 

The benefits of submitting a research poster abstract are:

  • All approved poster abstracts will be posted to NHF's 74th Bleeding Disorders Conference website one month prior to the start of the conference. Approved abstracts will be available online after the conference on the NHF website. The NHF Bleeding Disorders Conference is routinely attended by nearly 3,000 people, including physicians and other healthcare professionals, industry representatives, NHF chapters, patients, and families.
  • Research posters will be prominently displayed during NHF’s 74th Bleeding Disorders Conference in Houston, TX. 

General Instructions for Submitting Your Research Poster Abstract Online:

1. Register:

If you have not yet made a poster abstract submission to NHF’s 74th Bleeding Disorders Conference, you must first register your details with the abstracts submission system.

2. Prepare Abstract:

After registering, you will receive a confirmation e-mail with your login details.

All abstracts must be formatted as follows (please be as specific and thorough as possible in each instance): 

  • Objective
  • Methods
  • Summary (of results obtained)
  • Conclusions (it will not be sufficient to state – “results forthcoming”)

All abstracts must be 450 words or less. You are required to use 12pt Times New Roman font. It is not recommended that the abstract include graphs or a chart but, if necessary, they should be JGP files and fit within the maximum file size: 2 MB. If your abstract is approved, then graphs and charts should be in the poster.

3. Submit Abstract Online:

After preparing your abstract, log back into the system (submission link will be provided in the confirmation e-mail) and complete your submission following the instructions provided.

Important Information:

  • You will be able to make multiple submissions, append an existing submission, or finish the submission at a later time. 
  • Abstracts that have been previously presented elsewhere (i.e., encores) are permitted. 
  • Please be sure to submit your abstract by midnight Eastern Time, Monday, May 2, 2022. Alterations or revisions may be made up until this date.
  • Individuals who submit abstracts will be notified on Monday, June 13th about the decisions made by NHF’s peer review committee.
  • If your abstract is accepted by the peer review committee, then one of the authors must attend the conference to present the findings. There is no virtual option. 

We hope to post the abstracts on our website after BDC has concluded. General questions related to your submission can be sent to: posterabstract@hemophilia.org or call 212.328.3750.